Estabrook Capital Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.52M Buy
9,308
+1
+0% +$298 0.37% 58
2025
Q4
$3.07M Sell
9,307
-103
-1% -$34.9K 0.45% 53
2025
Q3
$3.25M Sell
9,410
-71
-0.7% -$21.5K 0.47% 51
2025
Q2
$2.96M Sell
9,481
-5,353
-36% -$2.05M 0.46% 55
2025
Q1
$7.77M Sell
14,834
-396
-3% -$202K 1.26% 22
2024
Q4
$7.7M Sell
15,230
-2,201
-13% -$1.25M 1.19% 24
2024
Q3
$10.2M Sell
17,431
-275
-2% -$156K 1.52% 18
2024
Q2
$9.02M Sell
17,706
-157
-0.9% -$77K 1.39% 20
2024
Q1
$8.84M Sell
17,863
-529
-3% -$269K 1.37% 22
2023
Q4
$9.68M Sell
18,392
-236
-1% -$126K 1.58% 17
2023
Q3
$9.39M Sell
18,628
-126
-0.7% -$62K 1.65% 17
2023
Q2
$9.01M Buy
18,754
+31
+0.2% +$15.2K 1.5% 20
2023
Q1
$8.85M Sell
18,723
-67
-0.4% -$32.3K 1.54% 20
2022
Q4
$9.96M Sell
18,790
-359
-2% -$190K 1.71% 17
2022
Q3
$9.67M Sell
19,149
-119
-0.6% -$62.6K 1.8% 14
2022
Q2
$9.9M Sell
19,268
-550
-3% -$276K 1.7% 20
2022
Q1
$10.1M Sell
19,818
-36
-0.2% -$17.4K 1.49% 22
2021
Q4
$9.97M Sell
19,854
-537
-3% -$243K 1.41% 22
2021
Q3
$7.97M Sell
20,391
-394
-2% -$163K 1.25% 25
2021
Q2
$8.32M Sell
20,785
-294
-1% -$117K 1.26% 26
2021
Q1
$7.84M Sell
21,079
-911
-4% -$316K 1.21% 26
2020
Q4
$7.71M Sell
21,990
-627
-3% -$210K 1.28% 24
2020
Q3
$7.05M Sell
22,617
-498
-2% -$153K 1.29% 22
2020
Q2
$6.82M Sell
23,115
-534
-2% -$153K 1.3% 24
2020
Q1
$5.9M Sell
23,649
-1,062
-4% -$292K 1.24% 24
2019
Q4
$7.26M Sell
24,711
-452
-2% -$118K 1.09% 30
2019
Q3
$5.47M Sell
25,163
-889
-3% -$215K 0.91% 37
2019
Q2
$6.36M Sell
26,052
-626
-2% -$151K 1.04% 31
2019
Q1
$6.6M Sell
26,678
-323
-1% -$82.4K 1.09% 30
2018
Q4
$6.73M Sell
27,001
-1,484
-5% -$392K 1.25% 28
2018
Q3
$7.58M Sell
28,485
-1,071
-4% -$279K 1.15% 28
2018
Q2
$7.25M Sell
29,556
-2,399
-8% -$576K 1.14% 29
2018
Q1
$6.84M Sell
31,955
-232
-0.7% -$53K 1.07% 32
2017
Q4
$7.1M Sell
32,187
-797
-2% -$169K 1.07% 32
2017
Q3
$6.46M Sell
32,984
-1,670
-5% -$323K 1% 36
2017
Q2
$6.43M Sell
34,654
-1,051
-3% -$184K 1.02% 37
2017
Q1
$5.86M Sell
35,705
-1,443
-4% -$236K 0.92% 37
2016
Q4
$5.95M Sell
37,148
-10,600
-22% -$1.58M 0.93% 37
2016
Q3
$6.68M Sell
47,748
-3,550
-7% -$497K 0.98% 39
2016
Q2
$7.24M Sell
51,298
-3,498
-6% -$466K 1.09% 37
2016
Q1
$7.06M Sell
54,796
-2,607
-5% -$308K 1.05% 37
2015
Q4
$6.75M Sell
57,403
-1,641
-3% -$192K 0.98% 36
2015
Q3
$6.85M Buy
59,044
+7,647
+15% +$915K 0.99% 37
2015
Q2
$6.27M Buy
51,397
+309
+0.6% +$36.6K 0.78% 41
2015
Q1
$6.04M Buy
51,088
+12,069
+31% +$1.34M 0.71% 41
2014
Q4
$3.94M Sell
39,019
-1,399
-3% -$133K 0.43% 49
2014
Q3
$3.49M Sell
40,418
-1,776
-4% -$150K 0.37% 50
2014
Q2
$3.45M Sell
42,194
-9,198
-18% -$724K 0.35% 53
2014
Q1
$4.21M Sell
51,392
-290
-0.6% -$21.8K 0.43% 52
2013
Q4
$3.89M Buy
51,682
+1,931
+4% +$139K 0.4% 53
2013
Q3
$3.56M Buy
49,751
+8,108
+19% +$580K 0.39% 52
2013
Q2
$2.73M Buy
+41,643
New +$2.59M 0.29% 62

Other funds holding UNH

Estabrook Capital Management's UNH Position: Q1 2026 in Review

Estabrook Capital Management increased its UnitedHealth (UNH) stake by 0.01% in Q1 2026, buying an estimated $298 and bringing the position to 9,308 shares worth $2.52M. The position accounts for 0.37% of the portfolio, ranked #58.

Estabrook Capital Management first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.2M in Q3 2024. 3,022 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Estabrook Capital Management held 9,308 shares of UnitedHealth worth $2.52M as of Q1 2026.
  • Estabrook Capital Management bought 1 UnitedHealth share in Q1 2026, an estimated $298.
  • UnitedHealth made up 0.37% of Estabrook Capital Management's portfolio in Q1 2026, its #58 holding.
  • Estabrook Capital Management first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
  • Estabrook Capital Management's UnitedHealth position peaked at $10.2M in Q3 2024.
  • 3,022 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.